Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$380K Sell
2,109
-5,289
-71% -$947K 0.01% 194
2019
Q1
$1.4M Sell
7,398
-446
-6% -$85.2K 0.06% 156
2018
Q4
$1.59M Buy
+7,844
New +$1.53M 0.07% 163

Other funds holding AMGN

Delek Group's AMGN Position: Q2 2019 in Review

Delek Group reduced its Amgen (AMGN) stake by 71% in Q2 2019, selling an estimated $947K and leaving 2,109 shares worth $380K. The position accounts for 0.01% of the portfolio, ranked #194.

Delek Group first reported a position in AMGN in Q4 2018 and has held it in 3 quarters since. The position peaked at $1.59M in Q4 2018. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Delek Group held 2,109 shares of Amgen worth $380K as of Q2 2019.
  • Delek Group sold 5,289 Amgen shares in Q2 2019, an estimated $947K.
  • Amgen made up 0.01% of Delek Group's portfolio in Q2 2019, its #194 holding.
  • Delek Group first reported a position in Amgen in Q4 2018 and has held it in 3 quarters since.
  • Delek Group's Amgen position peaked at $1.59M in Q4 2018.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.